STERIS plc (NYSE:STE) has gained traction among investors due to its essential role in delivering healthcare services, regardless of economic challenges. As a medical equipment company specializing in sterilization and surgical products for the US healthcare system, STE is poised to benefit from growing demand for its products.
The recent market downturn has led to renewed interest in dividend stocks, with the S&P Dividend Aristocrats Index falling by over 2% since the start of 2025. While some investors may view dividend cuts as a drawback, the fact remains that well-managed companies can still deliver stable returns through dividend payments.
STERIS plc (NYSE:STE) boasts strong balance sheets and solid financials, making it an attractive option for income investors. The company has reported significant revenue growth, driven by increases in consumable sales and service revenue, as well as a 9% rise in consumable sales and a 13% boost in service revenue.
The stock’s dividend yield of 1.01% is an additional appeal for income seekers. With a quarterly dividend payment of $0.57 per share, STE offers a reliable source of regular returns for investors.
STERIS plc (NYSE:STE) ranks high on the list of overlooked dividend stocks to buy now, and its performance has been driven by strong healthcare growth. As the company continues to benefit from growing demand for its products, investors may want to consider adding STE to their portfolios.
Source: https://finance.yahoo.com/news/steris-plc-ste-one-overlooked-215534127.html